AMRN (STOCKS)
Amarin Corp Plc
$14.510000
+0.030000 (+0.21%)
Prev close: $14.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Aaron D. Berg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $300.61M
- Employees
- 275
- P/E (TTM)
- -7.70
- P/B (TTM)
- 0.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.01 | $0.00 | +0.0100 | +0.00% |
|
Sep 2025 (Q3)
|
$0.08 | $-0.58 | +0.6614 | +113.76% |
|
Jun 2025 (Q2)
|
$0.66 | $-0.18 | +0.8402 | +466.26% |
|
Mar 2025 (Q1)
|
$-0.76 | $-0.58 | -0.1786 | -30.72% |
Financial Statements
| Revenues | $213.65M |
| Benefits Costs and Expenses | $249.69M |
| Cost Of Revenue | $92.78M |
| Costs And Expenses | $249.69M |
| Gross Profit | $120.87M |
| Operating Expenses | $171.04M |
| Selling, General, and Administrative Expenses | $115.00M |
| Research and Development | $19.81M |
| Other Operating Expenses | $36.23M |
| Operating Income/Loss | -$50.17M |
| Income/Loss From Continuing Operations After Tax | -$38.80M |
| Income/Loss From Continuing Operations Before Tax | -$36.05M |
| Income Tax Expense/Benefit | $2.75M |
| Income Tax Expense/Benefit, Current | $2.75M |
| Interest Expense, Operating | $7.00K |
| Net Income/Loss | -$38.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.09 |
| Basic Average Shares | 414,984,000 |
| Diluted Average Shares | 414,984,000 |
| Assets | $670.78M |
| Current Assets | $649.88M |
| Inventory | $195.91M |
| Other Current Assets | $453.97M |
| Noncurrent Assets | $20.89M |
| Fixed Assets | $12.00K |
| Other Non-current Assets | $20.88M |
| Liabilities | $211.49M |
| Current Liabilities | $194.46M |
| Accounts Payable | $45.36M |
| Wages | $11.32M |
| Other Current Liabilities | $137.78M |
| Noncurrent Liabilities | $17.04M |
| Equity | $459.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $459.28M |
| Liabilities And Equity | $670.78M |
| Net Cash Flow From Operating Activities | $6.73M |
| Net Cash Flow From Operating Activities, Continuing | $6.73M |
| Net Cash Flow From Investing Activities | $8.83M |
| Net Cash Flow From Investing Activities, Continuing | $8.83M |
| Net Cash Flow From Financing Activities | -$2.03M |
| Net Cash Flow From Financing Activities, Continuing | -$2.03M |
| Net Cash Flow | $13.52M |
| Net Cash Flow, Continuing | $13.52M |
| Comprehensive Income/Loss | -$38.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.80M |
| Other Comprehensive Income/Loss | $0.00 |